The Indian government imposes a 30% margin cap on 137 cancer drugs, leading to potential price reductions of up to 70% starting November 9

Updated 2026-10-19 · told from many outlets at once

India's government capped trade margins at 30% for 137 non-scheduled anti-cancer drugs. Prices of these drugs will drop by up to 70% starting November 9. Experts found average trade mark-ups on such drugs at 170 percent.

• The National Pharmaceutical Pricing Authority capped trade margins at 30% on 137 non-scheduled anti-cancer drug formulations.
• Experts found non-scheduled anti-cancer drugs have an average trade mark-up of 170 percent.
• The Supreme Court said all non-patented drugs and consumables should be price-controlled.
• Prices of 137 non-scheduled anti-cancer drugs are set to decrease by up to 70% starting November 9.

Outlets: Business Standard, Hindustan Times, Mint, The Indian Express, Times of India (Top)

Written by AI from the outlets' reporting and checked automatically; it can contain mistakes. How Daily Brief works · Privacy